Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,996 | 9,935 | 13,095 | 18,218 | 21,917 |
| Receivables | 1,445 | 1,215 | 652 | 1,077 | 1,003 |
| TOTAL | $8,826 | $11,580 | $14,256 | $19,660 | $24,492 |
| Non-Current Assets | |||||
| PPE Net | 127 | 153 | 181 | 211 | 244 |
| Other Non-Current Assets | 1,706 | 1,723 | 1,796 | 1,702 | 1,810 |
| TOTAL | $1,833 | $1,876 | $1,977 | $1,913 | $2,054 |
| Total Assets | $10,659 | $13,456 | $16,233 | $21,573 | $26,546 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,622 | 2,127 | 1,655 | 2,403 | 2,139 |
| TOTAL | $1,931 | $2,428 | $1,948 | $2,654 | $2,379 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,424 | 1,505 | 1,582 | 1,529 | 1,582 |
| TOTAL | $1,424 | $1,505 | $1,582 | $1,529 | $1,582 |
| Total Liabilities | $3,355 | $3,933 | $3,530 | $4,183 | $3,961 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,174 | 10,174 | 10,174 | 10,174 | 10,174 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -335,719 | -333,418 | -330,152 | -325,213 | -319,870 |
| TOTAL | $7,304 | $9,523 | $12,703 | $17,390 | $22,585 |
| Total Liabilities And Equity | $10,659 | $13,456 | $16,233 | $21,573 | $26,546 |